ArticleNPJ breast cancer2026

Evaluating the clinical utility of ctDNA testing to identify molecular cancer progression - lessons from SERENA-6.

Eleanor Taranto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.